Drug News

Added 11 hours ago Drug news

Five-year study of NX 1207 shows cut in surgery or radiotherapy for prostate cancer patients.

Nymox Pharmaceutical reported top-line 5-year results from Nymox's U.S. Study NX03-0040 of NX 1207 (fexapotide triflutate) in prostate cancer. 

Added 11 hours ago Drug news

EC approves Adcetris for CD30-positive cutaneous T-cell lymphoma.

The European Commission (EC) extended the current conditional marketing authorization of Adcetris (brentuximab vedotin).

Added 11 hours ago Drug news

Phase III study of Cinqair did not meet endpoint in Severe Eosinophilic Asthma.

No reduction in the frequency of clinical asthma exacerbations (CAEs).

Added 11 hours ago Drug news

Investigational DNA vaccine in unsuccessful trial

Phase III HELIOS trial of ASP 0113 fails to meet endpoints in cytomegalovirus.

Added 11 hours ago Drug news

FDA grants extended approval for Trisenox to treat acute promyelocytic leukemia

The approval was based on a Priority Review by the FDA on data from published scientific literature and a review of Teva’s global safety database for arsenic trioxide.

Added 11 hours ago Drug news

Chronic lymphocytic leukaemia treatment to be removed

Genmab announces it is removing Arzerra from the chronic lymphocytic leukaemia market outside the US.

Added 2 days ago Drug news

Triple combination therapy in colorectal cancer trial.

Phase III BEACON trial with Erbitux + LGX 818 + MEK 162 shows 8 month pfs in colorectal cancer.

Added 2 days ago Drug news

CE Mark for ingestible colorectal cancer capsule

Ingestible capsule for preparation-free colorectal cancer screening receives CE Mark

Added 2 days ago Drug news

Results announced for Checkmate trial evaluating Opdivo and Yervoy.

Positive CheckMate -142 trial for Opdivo and Yervoy for the treatment of patients with DNA mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal cancer. 

Added 2 days ago Drug news

LAPACT trial for pancreatic cancer results presented to American Society of Clinical Oncology

Abraxane + gemcitabine see positive results from LAPACT trial for locally advanced pancreatic cancer.

Search all news articles